Hepatitis B

November 15, 2016November 15, 2016

FDA Gives Gilead Sciences’ Vemlidy a Green Light for Hepatitis B Viral Treatment

Hepatitis B, News

Gilead Sciences’ Vemlidy (tenofovir alafenamide) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with chronic hepatitis B virus (HBV) infection with compensated ... Read more

November 10, 2016November 10, 2016

FDA Places Hold on Arrowhead’s Phase 2 HBV Clinical Trial

Hepatitis B, News

The U.S. Food and Drug Administration (FDA) placed a hold on Arrowhead Pharmaceuticals‘ Heparc-2004 Phase 2 clinical trial evaluating ARC-520, the company’s investigational medicine for the treatment of chronic hepatitis ... Read more

October 18, 2016October 18, 2016

ContraVir’s Lead Hepatitis B Candidate Advances in Phase 2a Trial

Hepatitis B, News

ContraVir has begun patient enrollment for the next dosing group in its Phase 2a clinical trial comparing the company’s CMX157 with Viread (tenofovir disoproxil fumarate) to treat chronic hepatitis B ... Read more

October 11, 2016October 11, 2016

New Biomarker May Identify Patients at Risk for Hep B Recurrence During Immunosuppressive Therapy

Hepatitis B, News

People who have an antigen called hepatitis B core-related antigen (HBcrAg) in their blood are nearly three times as likely to experience hepatitis B (HBV) recurrence when undergoing immunosuppressive therapy ... Read more

October 6, 2016October 6, 2016

FDA Warns Risk of Hepatitis B Reactivating with Certain Antiviral Drugs for Hepatitis C

Hepatitis B, Hepatitis C, News

Earlier this week, the U.S. Food and Drug Administration (FDA) warned about serious risks for patients infected with the hepatitis B virus (HBV) and who are being treated with certain direct-acting antiviral ... Read more

October 4, 2016October 4, 2016

Distrust and Stigmas Keep Australians with Hepatitis C from Seeking Treatment, Surveys Find

Hepatitis B, Hepatitis C, News

Patients with hepatitis C might be hesitant to seek life-saving treatment due to generalized feelings of mistrust toward the health system, and ongoing stigma from health workers toward injectable drug users, according to new research from the ... Read more

September 13, 2016September 13, 2016

Battle Against Hepatitis B Gains New Ally: Grass Pollen Allergy Vaccine

Hepatitis B, News

Researchers in Austria developed a new grass pollen allergy vaccine (BM32) that was found to have a potential hepatitis B infection-neutralizing activity. The study, “Immunotherapy With the PreS-based Grass Pollen ... Read more

July 26, 2016July 26, 2016

Phase 1/1b Trial for Chronic Hepatitis B Therapy to Continue, Based on Safety Panel Recommendation

Hepatitis B, News

Based on preliminary positive safety data, a Safety Review Committee has recommended that a Phase 1/1b clinical trial be continued with TG1050, an immunotherapy candidate being developed by Transgene for ... Read more

July 21, 2016July 21, 2016

UN Health Agency Warns ‘World Has Ignored Hepatitis at Its Peril’

Hepatitis B, Hepatitis C, News

Noting that an estimated 400 million people around the world are infected with hepatitis B or C, the United Nations health agency is encouraging countries to increase hepatitis testing and ... Read more

July 19, 2016July 19, 2016

Investigational RNAi Therapy for Chronic Hepatitis B Starts Phase 1/2 Trial

Hepatitis B, News

A new RNAi treatment candidate for chronic hepatitis B (HBV) infection called ALN-HBV, has entered a Phase 1/2 clinical trial to evaluate its safety and efficacy in healthy volunteers and HBV ... Read more